Jeffrey M. Drazen

Editor-in-Chief, New England Journal of Medicine

Physician scientist whose work helps define role of novel endogenous chemical agents in asthma, resulting in four new licensed pharmaceuticals for asthma; identified genetic component of variability of asthma treatment response. Since 2000, Editor-in-Chief, New England Journal of Medicine.

关于我们

加入我们

  • 登录
  • 成为我们的合作伙伴
  • 成为我们的会员
  • 订阅我们的新闻稿
  • 联系我们

快捷链接

语言版本

隐私政策和服务条款

站点地图

© 2025 世界经济论坛